Maxmed Life Sciences Private Limited, a active private limited company, was established on 14 June 2004 in South Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232DL2004PTC126912. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹2.50 Cr.
Formerly known as Kk Maxmed Private Limited. It upholds a compliant status. Employing 42 professional, Its leadership includes Shubham Wasan (Director), Sanjeev Wasan (Director). Past directors included Kulbhushan Kumar Wasan, Shubham Wasan, Dharmendra Kumar Singh. It holds ₹33.35 Cr open charges and ₹1.62 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at House No.12 Gang Dass Mohalla, Village - Aya Nagar New Delhi, South Delhi, Delhi, 110047.
U24232DL2004PTC126912
126912
14 June 2004
₹5.00 Cr
₹2.50 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Maxmed Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shubham Wasan | Director | 01 Jul 2019 | Current |
| Sanjeev Wasan | Director | 14 Jun 2004 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jul 2019 | Past |
| Pramod Abcsdd | Additional Director | 31 Oct 2024 | Past |
| Pramod Abcsdd | Whole-Time Director | 23 Mar 2021 | Past |
| Pramod Abcsdd | Additional Director | 13 May 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Maxmed Life Sciences Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.59% decrease. The company also saw a substantial fall in profitability, with a 28.14% decrease in profit. The company's net worth moved up by a moderate rise of 5.81%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Maxmed Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹333,525,263.00
₹16,200,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Nov 2025 | Hdfc Bank Limited | ₹7.95 Cr | Open |
| 05 Jan 2024 | Others | ₹10.50 Cr | Open |
| 25 May 2023 | Hdfc Bank Limited | ₹3.00 M | Open |
| 30 Sep 2019 | Others | ₹5.00 Cr | Open |
| 14 Feb 2015 | Hdfc Bank Limited | ₹5.95 Cr | Open |
Explore comprehensive loan charge details -
Maxmed Life Sciences has a workforce of 42 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Maxmed Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maxmed Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 7.95 Cr with Charge ID 101189775 was registered on 26 Nov 2025. was documented.
The activity A charge registered on 03 Oct 2020 via Charge ID 100377554 with Others was fully satisfied on 18 Jun 2025. was completed.
Progress on A charge with Hdfc Bank Limited of Rs. 3.65 Cr registered on 04 Nov 2013 with Charge ID 10462706 was modified on 28 Mar 2025. was documented.
Progress on A charge with Others of Rs. 10.50 Cr registered on 05 Jan 2024 with Charge ID 100871878 was modified on 03 Feb 2025. was documented.
Maxmed Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Maxmed Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
The CIN of Maxmed Life Sciences Private Limited is U24232DL2004PTC126912.
Maxmed Life Sciences Private Limited is headquartered at House No.12 Gang Dass Mohalla, Village - Aya Nagar New Delhi, South Delhi, Delhi, 110047.
Maxmed Life Sciences Private Limited was incorporated on 14 June 2004.
The current directors of Maxmed Life Sciences Private Limited are
The primary industry of Maxmed Life Sciences Private Limited is Manufacturing.
Maxmed Life Sciences Private Limited is unlisted.
The authorized capital of Maxmed Life Sciences Private Limited is ₹5.00 Cr, and the paid-up capital is ₹2.50 Cr.
The compliance status of Maxmed Life Sciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX